Axogen Inc vs Tesla, Inc. — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Tesla, Inc. trades at $396.67 (market cap $1.49T). The key difference: Tesla, Inc. is far larger — about 723.3× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals.
| AXGN | TSLA | |
|---|---|---|
Market Cap | $2.06B | $1.49T |
Sector | Technology | Consumer Cyclical |
52-Week High | $46.19 | $489.88 |
52-Week Low | $11.28 | $302.63 |
Enterprise Value | $1.98B | $1.46T |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Tesla (TSLA) trades at $394.76, down 3.18% today amid a bearish technical signal. The stock faces pressure from elevated valuations with a P/E of 362.17 and P/S of 14.25, while recent earnings show mixed results with a Q1 2026 beat but a Q3 2025 miss. Cash flow remains positive at $579M in 2025, though net income margins have compressed to 3.95% from prior years. News highlights focus on autonomous driving approvals in Europe and a potential cheaper EV model.
The outlook is cautious; while analyst consensus is a Buy with a $409.26 target, risks include intense EV competition, execution on AI/robotics bets, and high valuation multiples. Near-term performance hinges on Q2 2026 earnings and delivery growth, with support at $391 and resistance at $399.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →